Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-12,862
Closed -$4.45M 403
2021
Q2
$4.45M Sell
12,862
-2,070
-14% -$627K 0.35% 49
2021
Q1
$4.18M Sell
14,932
-9,238
-38% -$2.49M 0.36% 44
2020
Q4
$5.92M Sell
24,170
-572
-2% -$148K 0.56% 28
2020
Q3
$7.02M Buy
24,742
+19,870
+408% +$5.54M 0.73% 19
2020
Q2
$1.3M Buy
+4,872
New +$1.46M 0.14% 108
2018
Q3
Sell
-19,503
Closed -$5.66M 433
2018
Q2
$5.66M Buy
19,503
+176
+0.9% +$49.5K 0.6% 57
2018
Q1
$5.29M Buy
19,327
+1,653
+9% +$513K 0.59% 59
2017
Q4
$5.63M Buy
+17,674
New +$5.67M 0.65% 56

Other funds holding BIIB

6 Meridian's BIIB Position: Q3 2021 in Review

6 Meridian sold out of Biogen (BIIB) in Q3 2021, closing a stake of 12,862 shares — an estimated $4.45M sold.

6 Meridian first reported a position in BIIB in Q4 2017 and held it in 8 quarters. The position peaked at $7.02M in Q3 2020. 1,040 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • 6 Meridian reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • 6 Meridian sold 12,862 Biogen shares in Q3 2021, an estimated $4.45M.
  • 6 Meridian first reported a position in Biogen in Q4 2017 and held it in 8 quarters.
  • 6 Meridian's Biogen position peaked at $7.02M in Q3 2020.
  • 1,040 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on 6 Meridian's 13F filing for Q3 2021, filed 3 Nov 2021.